These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 34414960)

  • 1. Incidence of venous thromboembolism in rheumatoid arthritis, results from a "real-life" cohort and an appraisal of available literature.
    Conforti A; Berardicurti O; Pavlych V; Di Cola I; Cipriani P; Ruscitti P
    Medicine (Baltimore); 2021 Aug; 100(33):e26953. PubMed ID: 34414960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The risk and trend of pulmonary embolism and deep vein thrombosis in rheumatoid arthritis: a general population-based study.
    Li L; Lu N; Avina-Galindo AM; Zheng Y; Lacaille D; Esdaile JM; Choi HK; Aviña-Zubieta JA
    Rheumatology (Oxford); 2021 Jan; 60(1):188-195. PubMed ID: 32617563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of venous thromboembolism in patients with rheumatoid arthritis and association with disease duration and hospitalization.
    Holmqvist ME; Neovius M; Eriksson J; Mantel Ä; Wållberg-Jonsson S; Jacobsson LT; Askling J
    JAMA; 2012 Oct; 308(13):1350-6. PubMed ID: 23032551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of venous thromboembolism in patients with rheumatoid arthritis.
    Kim SC; Schneeweiss S; Liu J; Solomon DH
    Arthritis Care Res (Hoboken); 2013 Oct; 65(10):1600-7. PubMed ID: 23666917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of venous thromboembolism occurrence among adults with selected autoimmune diseases: a study among a U.S. cohort of commercial insurance enrollees.
    Yusuf HR; Hooper WC; Grosse SD; Parker CS; Boulet SL; Ortel TL
    Thromb Res; 2015 Jan; 135(1):50-7. PubMed ID: 25456001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Risk of Venous Thromboembolism in Rheumatoid Arthritis Patients Receiving Tofacitinib Versus Those Receiving Tumor Necrosis Factor Inhibitors: An Observational Cohort Study.
    Desai RJ; Pawar A; Weinblatt ME; Kim SC
    Arthritis Rheumatol; 2019 Jun; 71(6):892-900. PubMed ID: 30552833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venous thromboembolism and risk of cancer in patients with rheumatoid arthritis.
    Pedersen AB; Vandenbroucke J; Horváth-Puhó E; Sørensen HT
    J Thromb Haemost; 2017 Dec; 15(12):2325-2332. PubMed ID: 28913891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for venous thromboembolism and atherosclerotic cardiovascular disease: do they differ in patients with rheumatoid arthritis?
    Ozen G; Pedro S; Schumacher R; Simon T; Michaud K
    RMD Open; 2021 Jun; 7(2):. PubMed ID: 34193517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of venous thromboembolism in rheumatoid arthritis, and its association with disease activity: a nationwide cohort study from Sweden.
    Molander V; Bower H; Frisell T; Askling J
    Ann Rheum Dis; 2021 Feb; 80(2):169-175. PubMed ID: 33032998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of venous thromboembolism associated with methotrexate versus hydroxychloroquine for rheumatoid arthritis: A propensity score-matched cohort study.
    He M; Pawar A; Desai RJ; Glynn RJ; Lee H; Weinblatt ME; Solomon DH; Kim SC
    Semin Arthritis Rheum; 2021 Dec; 51(6):1242-1250. PubMed ID: 34757241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease activity as a risk factor for venous thromboembolism in rheumatoid arthritis analysed using time-averaged DAS28CRP: a nested case-control study.
    Yoshimura M; Fujieda Y; Sugawara M; Kono M; Kato M; Yokota I; Amengual O; Ito YM; Atsumi T
    Rheumatol Int; 2022 Nov; 42(11):1939-1946. PubMed ID: 35384451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of venous thromboembolism in rheumatoid arthritis.
    Ketfi C; Boutigny A; Mohamedi N; Bouajil S; Magnan B; Amah G; Dillinger JG
    Joint Bone Spine; 2021 May; 88(3):105122. PubMed ID: 33346109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk and complications of venous thromboembolism in dialysis patients.
    Molnar AO; Bota SE; McArthur E; Lam NN; Garg AX; Wald R; Zimmerman D; Sood MM
    Nephrol Dial Transplant; 2018 May; 33(5):874-880. PubMed ID: 28992258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High incidence of venous thromboembolism recurrence in patients with sickle cell disease.
    Brunson A; Keegan T; Mahajan A; White R; Wun T
    Am J Hematol; 2019 Aug; 94(8):862-870. PubMed ID: 31074115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of introducing biologics to patients with rheumatoid arthritis on the risk of venous thromboembolism: a nationwide cohort study.
    Chen CP; Kung PT; Chou WY; Tsai WC
    Sci Rep; 2021 Aug; 11(1):17009. PubMed ID: 34426637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venous thromboembolism risk is lower in patients with atopic dermatitis than other immune-mediated inflammatory diseases: A retrospective, observational, comparative cohort study using US claims data.
    Merola JF; Ertmer B; Liang H; Yue X; Ofori S; Krueger W
    J Am Acad Dermatol; 2024 May; 90(5):935-944. PubMed ID: 38147900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of venous thromboembolism in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a general population-based cohort study.
    Ogdie A; Kay McGill N; Shin DB; Takeshita J; Jon Love T; Noe MH; Chiesa Fuxench ZC; Choi HK; Mehta NN; Gelfand JM
    Eur Heart J; 2018 Oct; 39(39):3608-3614. PubMed ID: 28444172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of venous thromboembolism in immune-mediated inflammatory diseases: a UK matched cohort study.
    Galloway J; Barrett K; Irving P; Khavandi K; Nijher M; Nicholson R; de Lusignan S; Buch MH
    RMD Open; 2020 Sep; 6(3):. PubMed ID: 32994362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venous thromboembolism in ANCA-associated vasculitis: a population-based cohort study.
    Liapi M; Jayne D; Merkel PA; Segelmark M; Mohammad AJ
    Rheumatology (Oxford); 2021 Oct; 60(10):4616-4623. PubMed ID: 33506869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of statins and reduced risk of recurrence of VTE in an older population. A population-based cohort study.
    Tagalakis V; Eberg M; Kahn S; Azoulay L
    Thromb Haemost; 2016 Jun; 115(6):1220-8. PubMed ID: 26819144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.